Early systemic sclerosis manifests as Raynaud’s phenomenon, which can be controlled by treating skin and organ involvement with glucocorticoids and nifedipine.
Most early manifestations of systemic sclerosis are Raynaud’s phenomenon, which is a phenomenon in which the ends of the limbs become pale, purple and then flushed when stimulated by cold or emotional excitement.
In order to reduce the early or acute phase of skin edema, glucocorticosteroids such as prednisone acetate can be used as prescribed by the doctor, which is effective in inflammatory myopathy and the inflammatory phase of interstitial lung disease, but cannot prevent skin fibrosis. Blood pressure and renal function need to be monitored when glucocorticosteroids are used.
When Raynaud’s phenomenon occurs, it is necessary to quit smoking and keep hands and feet warm. Calcium channel blockers, such as nifedipine, can be used as prescribed. When Raynaud’s phenomenon is severe, 5-phosphodiesterase inhibitors such as fluoxetine can be used.
In the early stage of systemic scleroderma, you should go to the rheumatology and immunology department of the hospital in time, under the guidance of the doctor for treatment to control the progress of the disease.